
Piper Sandler Drops, Summit Therapeutics Jumps, Fair Isaac Sinks as New Policy Seen Spurring Competition
On this episode of Stock Movers:
-Piper Sandler (PIPR) shares drop after a report that the firm is in talks for a deal with Piper Sandler Cos., a transaction that would forge together two investment banks. While nothing is finalized, the banks could reach a deal soon, according to the Wall Street Journal, which cited people familiar with the matter that it didn’t identify.
-Summit Therapeutics (SMMT) shares climb. AstraZeneca agreed to invest $2 billion in the oncology drug developer to collaborate on its experimental treatment, ivonescimab. Analysts note the deal provides cash runway…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.